These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6421603)

  • 1. Antibody-free target cells stimulate chemiluminescence in polymorphonuclear leukocytes: an artifact due to mycoplasma contamination.
    Peterhans E; Bertoni G; Köppel P; Wyler R; Keller R
    Eur J Immunol; 1984 Feb; 14(2):201-3. PubMed ID: 6421603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of chemiluminescence during interaction of tumoricidal effector cell populations and tumor cells is dependent on the presence of mycoplasma.
    Köppel P; Peterhans E; Bertoni G; Keist R; Groscurth P; Wyler R; Keller R
    J Immunol; 1984 Apr; 132(4):2021-9. PubMed ID: 6607953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of NKCF-like activity in mixed lymphocyte-tumor cell culture: direct involvement of mycoplasma infection of tumor cells.
    Wayner EA; Brooks CG
    J Immunol; 1984 Apr; 132(4):2135-42. PubMed ID: 6230401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cellular chemiluminescence of activated phagocytes of whole blood].
    Krause S; Michel E; Brachmann P; Lösche W; Heptinstall S; Till U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):955-65. PubMed ID: 2483714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell lines.
    Wright SC; Bonavida B
    J Immunol; 1984 Dec; 133(6):3415-23. PubMed ID: 6491292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting the measurement of chemiluminescence in stimulated human polymorphonuclear leucocytes.
    Harber MJ; Topley N
    J Biolumin Chemilumin; 1986 Jun; 1(1):15-27. PubMed ID: 3503523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High nonspecific reactivity of normal lymphocytes against mycoplasma-infected target cells in cytotoxicity assays.
    Brooks CG; Rees RC; Leach RH
    Eur J Immunol; 1979 Feb; 9(2):159-65. PubMed ID: 436929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of different chemilumigenic substrates for detecting extracellular generation of reactive oxygen species by phagocytes and endothelial cells.
    Kopprasch S; Pietzsch J; Graessler J
    Luminescence; 2003; 18(5):268-73. PubMed ID: 14587078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytotoxic action of polymorphonuclear leukocytes on tumor and normal cells during ascite tumor development in vitro and in vivo].
    Potselueva MM; Pustovidko AV; Kovaleva EV; Shatalin IuV; Evdotienko IuV
    Tsitologiia; 2005; 47(1):57-63. PubMed ID: 16602244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-activated NK cells trigger monocyte oxidative metabolism.
    Pohajdak B; Gomez JL; Wilkins JA; Greenberg AH
    J Immunol; 1984 Nov; 133(5):2430-6. PubMed ID: 6434630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of catecholamines on the luminol-dependent chemiluminescence of rat polymorphonuclear leukocytes].
    Potselueva MM; Marinov BS; Pustovidko AV; Kudzina LIu; Evtodienko IuV
    Tsitologiia; 1997; 39(8):699-704. PubMed ID: 9490508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of the effector cells mediating cytotoxicity against antibody-coated target cells. I. Phagocytic and non-phagocytic effector cell activity against erythrocyte and tumour target cells in a 51Cr release cytotoxicity assay and [125I]IUdR growth inhibition assay.
    Greenberg AH; Shen L; Medley G
    Immunology; 1975 Oct; 29(4):719-29. PubMed ID: 810417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compared mechanisms of tumor cytolysis by human natural killer cells and activated polymorphonuclear leukocytes.
    Abrams SI; Brahmi Z
    J Immunol; 1984 Jun; 132(6):3192-6. PubMed ID: 6327820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemiluminescence measurements of immune cells--a tool in immunobiology and clinical research.
    Ernst M; Heberer M; Fischer H
    J Clin Chem Clin Biochem; 1983 Sep; 21(9):555-60. PubMed ID: 6355369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-dependent cellular cytotoxicity and chemiluminescence as a tool for studying the mechanism of anti-glomerular basement membrane nephritis. The role of the cytotoxic potential of polymorphonuclear granulocytes and monocytes.
    Mossmann H; Hoyer B; Walz W; Himmelspach K; Hammer DK
    Immunology; 1984 Nov; 53(3):545-52. PubMed ID: 6490096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrasting effects of Mycoplasma fermentans and M. felis on the viability and chemiluminescence response of human polymorphonuclear leukocytes.
    Marshall A; Miles RJ; Richards L
    FEMS Microbiol Lett; 1993 May; 109(2-3):167-71. PubMed ID: 8339908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemiluminescence response of phagocytes in E. coli induced experimental ascending pyelonephritis.
    Gupta A; Kaur A; Majumdar S; Sharma BK; Ganguly NK
    Biochem Int; 1992 Feb; 26(1):43-50. PubMed ID: 1616496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of chemiluminescence in bovine polymorphonuclear leucocytes by virus-antibody complexes and by antibody-coated infected cells.
    Weber L; Peterhans E
    Immunobiology; 1983 May; 164(5):333-42. PubMed ID: 6307864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of human polymorphonuclear leucocytes by particulate zymosan is related to both its major carbohydrate components: glucan and mannan.
    Williams JD; Topley N; Alobaidi HM; Harber MJ
    Immunology; 1986 May; 58(1):117-24. PubMed ID: 3710519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxygen radical generation by polymorphonuclear leucocytes of beige mice.
    Kubo A; Sasada M; Nishimura T; Moriguchi T; Kakita T; Yamamoto K; Uchino H
    Clin Exp Immunol; 1987 Dec; 70(3):658-63. PubMed ID: 2830072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.